These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 36726376)

  • 1. Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis.
    Bahramy A; Zafari N; Rajabi F; Aghakhani A; Jayedi A; Khaboushan AS; Zolbin MM; Yekaninejad MS
    Front Mol Biosci; 2023; 10():1096524. PubMed ID: 36726376
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of non-coding RNAs related to the tumorigenic epithelial-mesenchymal transition (EMT) process among ovarian cancer patients: A systematic review and meta-analysis.
    Soltani Khaboushan A; Salimian SN; Mehraban S; Bahramy A; Zafari N; Kajbafzadeh AM; Johnson J; Majidi Zolbin M
    Heliyon; 2024 Aug; 10(16):e35202. PubMed ID: 39253159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
    Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
    Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic potential of exosome non-coding RNAs in bladder cancer: a systematic review and meta-analysis.
    Chen Y; Shi K; Fu X; Guo H; Gao T; Yu H
    Front Oncol; 2024; 14():1336375. PubMed ID: 38500660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis.
    Mardani M; Rashedi S; Keykhaei M; Farrokhpour H; Azadnajafabad S; Tavolinejad H; Rezaei N
    Pathol Res Pract; 2022 Jan; 229():153726. PubMed ID: 34942515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Non-coding RNAs as Potential Biomarkers for Ischemic Stroke: A Systematic Review.
    Zhao J; Wang Q; Zhu R; Yang J
    J Mol Neurosci; 2022 Aug; 72(8):1572-1585. PubMed ID: 35380333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis.
    Li C; Yuan Q; Deng T; Xu G; Hou J; Zheng L; Wu G
    Breast Cancer; 2023 Nov; 30(6):965-975. PubMed ID: 37470943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.
    Zheng C; Liu X; Chen L; Xu Z; Shao J
    Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis.
    Gheytanchi E; Tajik F; Razmi M; Babashah S; Cho WCS; Tanha K; Sahlolbei M; Ghods R; Madjd Z
    Cancer Cell Int; 2023 Jan; 23(1):10. PubMed ID: 36670440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.
    Tian T; Wang M; Lin S; Guo Y; Dai Z; Liu K; Yang P; Dai C; Zhu Y; Zheng Y; Xu P; Zhu W; Dai Z
    Mol Ther Nucleic Acids; 2018 Sep; 12():359-369. PubMed ID: 30195774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.
    Su G; He Q; Wang J
    Front Physiol; 2018; 9():652. PubMed ID: 29899709
    [No Abstract]   [Full Text] [Related]  

  • 15. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
    Ke L; Li S; Cui H
    BMC Cancer; 2022 Nov; 22(1):1185. PubMed ID: 36397030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCNB2 expression correlates with worse outcomes in breast cancer patients: a pooled analysis.
    Sun C; Lowe S; Ma S; Bentley R; Zhou Z; Cheng C; Zhou Q
    Women Health; 2022 Aug; 62(7):655-663. PubMed ID: 35892137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis.
    Tang S; Fan W; Xie J; Deng Q; Wang P; Wang J; Xu P; Zhang Z; Li Y; Yu M
    Oncotarget; 2017 Oct; 8(46):81215-81225. PubMed ID: 29113381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis.
    Tan G; Chu C; Gui X; Li J; Chen Q
    Medicine (Baltimore); 2018 Mar; 97(13):e0197. PubMed ID: 29595655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis.
    Nie G; Lian N; Peng D; Lu J; Li B
    Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
    Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
    Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.